Publikationen in Zusammenarbeit mit Forschern von University of Queensland (11)

2024

  1. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

    Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 5

2022

  1. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set

    Critical Care, Vol. 26, Núm. 1

  2. Correction: Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set (Critical Care, (2022), 26, 1, (236), 10.1186/s13054-022-04108-8)

    Critical Care

  3. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

    Scientific Data, Vol. 9, Núm. 1

2019

  1. Factors associated with ventilator-associated events: an international multicenter prospective cohort study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 9, pp. 1693-1699

2018

  1. Assessing predictive accuracy for outcomes of ventilator-associated events in an international cohort: the EUVAE study

    Intensive Care Medicine, Vol. 44, Núm. 8, pp. 1212-1220

2016

  1. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 1, pp. 196-207

2014

  1. Assessment of the worldwide burden of critical illness: The Intensive Care Over Nations (ICON) audit

    The Lancet Respiratory Medicine, Vol. 2, Núm. 5, pp. 380-386

  2. DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients?

    Clinical Infectious Diseases, Vol. 58, Núm. 8, pp. 1072-1083

  3. Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study

    International Journal of Antimicrobial Agents, Vol. 43, Núm. 5, pp. 423-430